ACKR3 and neoplasm: Four weeks after the treatment, the tumour size in the CXCR7‐shRNA + TACE group was significantly smaller than in the other three groups (all P < 0.01), and the sizes in the CXCR7‐shRNA and TACE groups were significantly smaller than in the control group (both P < 0.01).